254 related articles for article (PubMed ID: 11525697)
1. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
Hull RD; Pineo GF; Stein PD; Mah AF; MacIsaac SM; Dahl OE; Ghali WA; Butcher MS; Brant RF; Bergqvist D; Hamulyák K; Francis CW; Marder VJ; Raskob GE
Arch Intern Med; 2001 Sep; 161(16):1952-60. PubMed ID: 11525697
[TBL] [Abstract][Full Text] [Related]
2. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?
Strebel N; Prins M; Agnelli G; Büller HR
Arch Intern Med; 2002 Jul; 162(13):1451-6. PubMed ID: 12090880
[TBL] [Abstract][Full Text] [Related]
3. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
Hull RD; Pineo GF; Stein PD; Mah AF; MacIsaac SM; Dahl OE; Butcher M; Brant RF; Ghali WA; Bergqvist D; Raskob GE
Ann Intern Med; 2001 Nov; 135(10):858-69. PubMed ID: 11712876
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators.
Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
Arch Intern Med; 2000 Jul; 160(14):2199-207. PubMed ID: 10904464
[TBL] [Abstract][Full Text] [Related]
5. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.
Samama CM; Vray M; Barré J; Fiessinger JN; Rosencher N; Lecompte T; Potron G; Basile J; Hull R; Desmichels D;
Arch Intern Med; 2002 Oct; 162(19):2191-6. PubMed ID: 12390061
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin prophylaxis: preoperative versus postoperative initiation in patients undergoing elective hip surgery.
Hull RD; Pineo GF; MacIsaac S
Thromb Res; 2001 Jan; 101(1):V155-62. PubMed ID: 11342095
[TBL] [Abstract][Full Text] [Related]
7. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.
Raskob GE; Hirsh J
Chest; 2003 Dec; 124(6 Suppl):379S-385S. PubMed ID: 14668421
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
9. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
10. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
Douketis JD; Eikelboom JW; Quinlan DJ; Willan AR; Crowther MA
Arch Intern Med; 2002 Jul; 162(13):1465-71. PubMed ID: 12090882
[TBL] [Abstract][Full Text] [Related]
11. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
Eikelboom JW; Quinlan DJ; Douketis JD
Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
Gould MK; Dembitzer AD; Doyle RL; Hastie TJ; Garber AM
Ann Intern Med; 1999 May; 130(10):800-9. PubMed ID: 10366369
[TBL] [Abstract][Full Text] [Related]
13. Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement.
Hull RD; Brant RF; Pineo GF; Stein PD; Raskob GE; Valentine KA
Arch Intern Med; 1999 Jan; 159(2):137-41. PubMed ID: 9927095
[TBL] [Abstract][Full Text] [Related]
14. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
[TBL] [Abstract][Full Text] [Related]
15. Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty.
Lassen MR; Borris LC; Jensen HP; Poulsen KA; Ejstrud P; Andersen BS
Clin Appl Thromb Hemost; 2000 Jan; 6(1):53-7. PubMed ID: 10726050
[TBL] [Abstract][Full Text] [Related]
16. Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
Mrozik D; Jackiewicz A; Krzemiński M
Pol Orthop Traumatol; 2012 Oct; 77():111-4. PubMed ID: 23306297
[TBL] [Abstract][Full Text] [Related]
17. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.
Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
Arch Intern Med; 2000 Jul; 160(14):2208-15. PubMed ID: 10904465
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty.
Anderson DR; O'Brien BJ; Levine MN; Roberts R; Wells PS; Hirsh J
Ann Intern Med; 1993 Dec; 119(11):1105-12. PubMed ID: 8239230
[TBL] [Abstract][Full Text] [Related]
20. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
